Charles River Laboratories International valuation
Valuation
The P/E ratio is 367.4. The average price target of 14 analysts is $350.57.
Data as of November 16, 2026
Charles River Laboratories International compared with similar companies
Charles River Laboratories International's P/E (trailing 12 months): 367.4, +873% against the median of a group of 9 similar companies (37.7).
| Metric | Charles River Laboratories International | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 367.4 | 37.7 | 32.3 – 68.6 | High |
| Forward P/E | 26.1 | 25.9 | 18.9 – 32.7 | Middle |
| EV/EBITDA | 20.8 | 21.5 | 18.5 – 28.3 | Middle |
| Price/book | 5.01 | 5.79 | 3.49 – 21.0 | Middle |
| Price/sales | 4.07 | 5.86 | 2.47 – 7.57 | Middle |
| Gross margin | 35.1% | 55.9% | 33.1% – 65.2% | Middle |
| Operating margin | 14.3% | 14.3% | 6.9% – 17.9% | Middle |
| Net margin | 1.0% | 8.1% | 3.1% – 13.9% | Low |
| ROE | 1.3% | 11.4% | 2.4% – 26.9% | Low |
| Debt/equity | 0.87 | 0.74 | 0.34 – 0.83 | High |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Charles River Laboratories International: valuation over time
Charles River Laboratories International P/E and dividend yield at each fiscal year end, 2016 to 2025.
| Fiscal year | Price at year end | Earnings per share | P/E |
|---|---|---|---|
| 2025 | $203.66 | -$2.91 | — |
| 2024 | $186.16 | $0.20 | — |
| 2023 | $236.40 | $9.22 | 25.6 |
| 2022 | $217.90 | $9.48 | 23.0 |
| 2021 | $369.20 | $7.60 | 48.6 |
| 2020 | $251.71 | $7.20 | 35.0 |
| 2019 | $151.93 | $5.07 | 30.0 |
| 2018 | $111.72 | $4.62 | 24.2 |
| 2017 | $109.45 | $2.54 | 43.1 |
| 2016 | $76.19 | $3.23 | 23.6 |
TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only). Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above.
TickerLandia analysisHow it is calculated
Other metrics
Valuation multiples
- Market cap
- $16.19B
- Enterprise value
- $18.89B
- PEG
- 0.12
- EV/revenue
- 4.75
Profitability and growth
- ROA
- 4.7%
- ROIC
- 5.8%
- Revenue growth (year over year)
- -2.2%
- Earnings growth (year over year)
- 523.6%
Financial health
- Total cash
- $200.38M
- Total debt
- $2.85B
- Current ratio
- 1.41
- Quick ratio
- 0.86
- Altman Z-Score
- 2.58
- Piotroski F-Score
- 7.00
Dividends
- Dividend yield
- 0.0%
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- $350.57
- Median price target
- $375.00
- High price target
- $400.00
- Low price target
- $145.00
- Analysts with a price target
- 14
- Consensus
- Buy
- Forward EPS
- $12.97
- EPS estimate, current year
- $11.47
Shares and trading
- Beta
- 1.34
- Average volume
- 1.05M
- Shares outstanding
- 47.92M
- Float
- 47.4M
- Institutional ownership
- 115.5%
- Insider ownership
- 1.5%
- Short interest (% of float)
- 7.2%
- Short ratio (days)
- 2.61
